BCOP Practice Questions - Board Certified Oncology Pharmacist Exam

Which molecular alteration defines Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML)?

BCR-ABL1 fusion JAK2 V617F mutation FLT3-ITD mutation PML-RARA fusion

BCR-ABL1 fusion

Access more questions from this quiz

Continue to BCOP Practice Questions - Board Certified Oncology Pharmacist Exam for more practice questions and the full quiz experience.